View in EDS

Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.

Saved in:
Bibliographic Details
Title: Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.
Authors: Ku G; Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: kug@mskcc.org., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital and Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Park H; Washington University School of Medicine, St Louis, USA., Lam VK; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA., George TJ; University of Florida Health Cancer Center, Gainesville, USA., Kim SS; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, USA., Gutierrez M; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, USA., Shankaran V; University of Washington School of Medicine, Seattle, USA., Stein S; Yale University School of Medicine, New Haven, USA., Denlinger CS; Fox Chase Cancer Center, Philadelphia, USA., Elimova E; Princess Margaret Cancer Centre, Toronto, Canada., Nagrial A; Department of Medical Oncology, Westmead Hospital, University of Sydney, Sydney, Australia., He AR; Georgetown University Medical Center, Washington, USA., Sawyer MB; Cross Cancer Institute, University of Alberta, Edmonton, Canada., Yoon HH; Mayo Clinic, Rochester, USA., Geva R; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Starr J; Mayo Clinic, Jacksonville, USA., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy., Golan T; Sheba Medical Center, Tel-Aviv University, Tel Aviv, Israel., von Moos R; Cancer Center, Kantonsspital Graubünden, Chur, Switzerland., Fritsch R; Department of Medical Oncology and Hematology, Universitätsspital Zürich, Zurich, Switzerland., Lim D; City of Hope National Medical Center, Duarte, USA., Wang Q; Bristol Myers Squibb, Princeton, USA., Patel A; Bristol Myers Squibb, Princeton, USA., Aoyama T; Bristol Myers Squibb, Princeton, USA., Lei M; Bristol Myers Squibb, Princeton, USA., Greenawalt D; Bristol Myers Squibb, Princeton, USA., Di Bartolomeo M; Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy.
Source: ESMO open [ESMO Open] 2025 Feb; Vol. 10 (2), pp. 104107. Date of Electronic Publication: 2025 Jan 10.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39798422
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ku+G%22">Ku G</searchLink>; Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: kug@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Haag+GM%22">Haag GM</searchLink>; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital and Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Washington University School of Medicine, St Louis, USA.<br /><searchLink fieldCode="AU" term="%22Lam+VK%22">Lam VK</searchLink>; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.<br /><searchLink fieldCode="AU" term="%22George+TJ%22">George TJ</searchLink>; University of Florida Health Cancer Center, Gainesville, USA.<br /><searchLink fieldCode="AU" term="%22Kim+SS%22">Kim SS</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, USA.<br /><searchLink fieldCode="AU" term="%22Gutierrez+M%22">Gutierrez M</searchLink>; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, USA.<br /><searchLink fieldCode="AU" term="%22Shankaran+V%22">Shankaran V</searchLink>; University of Washington School of Medicine, Seattle, USA.<br /><searchLink fieldCode="AU" term="%22Stein+S%22">Stein S</searchLink>; Yale University School of Medicine, New Haven, USA.<br /><searchLink fieldCode="AU" term="%22Denlinger+CS%22">Denlinger CS</searchLink>; Fox Chase Cancer Center, Philadelphia, USA.<br /><searchLink fieldCode="AU" term="%22Elimova+E%22">Elimova E</searchLink>; Princess Margaret Cancer Centre, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Nagrial+A%22">Nagrial A</searchLink>; Department of Medical Oncology, Westmead Hospital, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22He+AR%22">He AR</searchLink>; Georgetown University Medical Center, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Sawyer+MB%22">Sawyer MB</searchLink>; Cross Cancer Institute, University of Alberta, Edmonton, Canada.<br /><searchLink fieldCode="AU" term="%22Yoon+HH%22">Yoon HH</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Geva+R%22">Geva R</searchLink>; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Starr+J%22">Starr J</searchLink>; Mayo Clinic, Jacksonville, USA.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Golan+T%22">Golan T</searchLink>; Sheba Medical Center, Tel-Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22von+Moos+R%22">von Moos R</searchLink>; Cancer Center, Kantonsspital Graubünden, Chur, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fritsch+R%22">Fritsch R</searchLink>; Department of Medical Oncology and Hematology, Universitätsspital Zürich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lim+D%22">Lim D</searchLink>; City of Hope National Medical Center, Duarte, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Bristol Myers Squibb, Princeton, USA.<br /><searchLink fieldCode="AU" term="%22Patel+A%22">Patel A</searchLink>; Bristol Myers Squibb, Princeton, USA.<br /><searchLink fieldCode="AU" term="%22Aoyama+T%22">Aoyama T</searchLink>; Bristol Myers Squibb, Princeton, USA.<br /><searchLink fieldCode="AU" term="%22Lei+M%22">Lei M</searchLink>; Bristol Myers Squibb, Princeton, USA.<br /><searchLink fieldCode="AU" term="%22Greenawalt+D%22">Greenawalt D</searchLink>; Bristol Myers Squibb, Princeton, USA.<br /><searchLink fieldCode="AU" term="%22Di+Bartolomeo+M%22">Di Bartolomeo M</searchLink>; Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2025 Feb; Vol. 10 (2), pp. 104107. <i>Date of Electronic Publication: </i>2025 Jan 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39798422
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2024.104107
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104107
    Titles:
      – TitleFull: Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ku G
      – PersonEntity:
          Name:
            NameFull: Haag GM
      – PersonEntity:
          Name:
            NameFull: Park H
      – PersonEntity:
          Name:
            NameFull: Lam VK
      – PersonEntity:
          Name:
            NameFull: George TJ
      – PersonEntity:
          Name:
            NameFull: Kim SS
      – PersonEntity:
          Name:
            NameFull: Gutierrez M
      – PersonEntity:
          Name:
            NameFull: Shankaran V
      – PersonEntity:
          Name:
            NameFull: Stein S
      – PersonEntity:
          Name:
            NameFull: Denlinger CS
      – PersonEntity:
          Name:
            NameFull: Elimova E
      – PersonEntity:
          Name:
            NameFull: Nagrial A
      – PersonEntity:
          Name:
            NameFull: He AR
      – PersonEntity:
          Name:
            NameFull: Sawyer MB
      – PersonEntity:
          Name:
            NameFull: Yoon HH
      – PersonEntity:
          Name:
            NameFull: Geva R
      – PersonEntity:
          Name:
            NameFull: Starr J
      – PersonEntity:
          Name:
            NameFull: Curigliano G
      – PersonEntity:
          Name:
            NameFull: Golan T
      – PersonEntity:
          Name:
            NameFull: von Moos R
      – PersonEntity:
          Name:
            NameFull: Fritsch R
      – PersonEntity:
          Name:
            NameFull: Lim D
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Patel A
      – PersonEntity:
          Name:
            NameFull: Aoyama T
      – PersonEntity:
          Name:
            NameFull: Lei M
      – PersonEntity:
          Name:
            NameFull: Greenawalt D
      – PersonEntity:
          Name:
            NameFull: Di Bartolomeo M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1